THSP
CLLS

Taube Hodson Stonex Partners’s Cellectis CLLS Stock Holding History

Taube Hodson Stonex Partners’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$7.17M Buy
269,776
+99,664
+59% +$2.92M 1.47% 17
2016
Q1 		$4.68M Buy
+170,112
New +$4.1M 0.9% 18

Other funds holding CLLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return

Taube Hodson Stonex Partners's CLLS Position: Q2 2016 in Review

Taube Hodson Stonex Partners increased its Cellectis (CLLS) stake by 59% in Q2 2016, buying an estimated $2.92M and bringing the position to 269,776 shares worth $7.17M. The position accounts for 1.47% of the portfolio, ranked #17.

Taube Hodson Stonex Partners first reported a position in CLLS in Q1 2016 and has held it in 2 quarters since. 38 funds tracked by Wall St. Rank hold CLLS as of Q2 2016.

  • Taube Hodson Stonex Partners held 269,776 shares of Cellectis worth $7.17M as of Q2 2016.
  • Taube Hodson Stonex Partners bought 99,664 Cellectis shares in Q2 2016, an estimated $2.92M.
  • Cellectis made up 1.47% of Taube Hodson Stonex Partners's portfolio in Q2 2016, its #17 holding.
  • Taube Hodson Stonex Partners first reported a position in Cellectis in Q1 2016 and has held it in 2 quarters since.
  • 38 funds tracked by Wall St. Rank held Cellectis as of Q2 2016.

Based on Taube Hodson Stonex Partners's 13F filing for Q2 2016, filed 15 Jul 2016.